Corporate News     07-May-19
Unichem Laboratories receives approval from USFDA for hydrocloride tablets
On 07 May 2019
Unichem Laboratories Limited announced that it received tentative ANDA approval from USFDA for Unichem's Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets USP, 5 mg/120 mg (OTC) to market a generic version of Johnson and Johnson Consumer Inc's Zyrtec-D 12 Hour (Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride, 5mg/120 mg) Extended Tablets. These are indicated for antihistamine and nasal decongestant. The Product will be commercialized from Unichemls Goa Plant on receipt of final approval.
Previous News
  Unichem Laboratories reports consolidated net loss of Rs 63.93 crore in the December 2022 quarter
 ( Results - Announcements 06-Feb-23   16:14 )
  Unichem Laboratories AGM scheduled
 ( Corporate News - 24-Aug-23   14:41 )
  Board of Ipca Laboratories approves acquisition of 33.38% stake in Unichem Laboratories
 ( Corporate News - 24-Apr-23   16:06 )
  Unichem Laboratories schedules board meeting
 ( Corporate News - 01-Aug-22   15:58 )
  Unichem Laboratories standalone net profit rises 341.78% in the March 2019 quarter
 ( Results - Announcements 25-May-19   15:12 )
  Unichem Laboratories to convene board meeting
 ( Corporate News - 04-Nov-22   14:16 )
  Unichem Laboratories to conduct AGM
 ( Corporate News - 30-Jun-22   11:21 )
  Unichem Laboratories gets USFDA approval for Pramipexole Dihydrochloride Tablets
 ( Corporate News - 21-Dec-18   16:32 )
  Board of Unichem Laboratories recommends Final Dividend
 ( Corporate News - 25-May-19   14:04 )
  Unichem Laboratories allots 6075 equity shares
 ( Corporate News - 28-Jul-18   14:55 )
  Unichem Lab extends Thursday's slump
 ( Hot Pursuit - 11-Jul-14   13:04 )
Other Stories
  GRP schedules AGM
  01-Jul-24   20:01
  Mahindra & Mahindra domestic PV sales jump 23% in June
  01-Jul-24   20:01
  Vipul Organics constructs new factory in Ambernath, Maharashtra
  01-Jul-24   20:00
  Greaves Engineering launches range of new CPCB IV+ Compliant Gensets
  01-Jul-24   19:41
  Godrej Properties to develop 7-acre land in Thanisandra, North Bengaluru
  01-Jul-24   19:39
  Rama Phosphates AGM scheduled
  01-Jul-24   19:34
  Take Solutions to convene AGM
  01-Jul-24   19:34
  Fischer Medical Ventures partners with Singapore-based Nervotec
  01-Jul-24   19:29
  NIIT appoints Pankaj Jathar as Chief Executive Officer
  01-Jul-24   19:27
  Dynacons Systems recognized as India's Leading Listed ESG Entities 2024
  01-Jul-24   19:26
Back Top